Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
Rongyan Zhao, Jia Fu, Lingjuan Zhu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Targeting and engineering long non-coding RNAs for cancer therapy
Michela Coan, Simon Haefliger, Samir Ounzain, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 578-595
Closed Access | Times Cited: 41
New insight into circRNAs: characterization, strategies, and biomedical applications
Xin-Yi Feng, Shun-Xin Zhu, Ke‐Jia Pu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer
Katia Grillone, Giulio Caridà, Francesco Luciano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155303-155303
Closed Access | Times Cited: 12
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 11
Advanced approaches of the use of circRNAs as a replacement for cancer therapy
Goran Sedeeq Hama Faraj, Bashdar Mahmud Hussen, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 811-830
Open Access | Times Cited: 8
Bioinformatic database, artificial intelligence and machine learning-based tools for non-coding RNA study
Karen P. Pachchigar, Darshan T. Dharajiya, Gaurav S. Dave, et al.
Elsevier eBooks (2025), pp. 51-75
Closed Access
αAsarone alleviates neuronal injury by facilitating autophagy via miR-499-5p/PDCD4/ATG5 signaling pathway in ischemia stroke
Yonghuan Yan, Linfang Wu, Lu Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Synthesis and Antibacterial Activity of 4-Oxo-2-thienylaminobut-2-enoic Acids
I. A. Gorbunova, V. M. Shadrin, Н. А. Пулина, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 1, pp. 8-15
Closed Access | Times Cited: 17
ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
Jia Fu, Jin Zhang, Xiya Chen, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 787-809
Open Access | Times Cited: 15
Decyclization of Substituted 2-[2-Oxofuran-3(2H)-ylidene)furan-2-carbohydrazides by the Action of Alcohols and Analgesic Activity of the Obtained Compounds
S. N. Igidov, A. Yu. Turyshev, Р. Р. Махмудов, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 2, pp. 253-262
Closed Access | Times Cited: 14
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 5
METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization
Xiaodong Ling, Cuicui Qi, Kui Cao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Synthesis, Intramolecular Cyclization, and Analgesic Activity of Substituted 2-[2-(Furancarbonyl)hydrazinylydene]-4-oxobutanoic Acids
S. N. Igidov, A. Yu. Turyshev, Р. Р. Махмудов, et al.
Russian Journal of General Chemistry (2022) Vol. 92, Iss. 9, pp. 1629-1636
Closed Access | Times Cited: 22
Synthesis and Antinociceptive Activity of Substituted 2-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thiophene-2-ylamino)-4-oxobut-2-enoates
I. A. Gorbunova, Yu. O. Sharavyeva, Р. Р. Махмудов, et al.
Russian Journal of General Chemistry (2022) Vol. 92, Iss. 10, pp. 1899-1905
Closed Access | Times Cited: 22
Synthesis, Intramolecular Cyclization, and Anti-inflammatory Activity of Substituted 2-[2-(4-R-Benzoyl)hydrazinylidene]-4-oxobutanoic Acids
D. V. Lipin, E. I. Denisova, D. A. Shipilovskikh, et al.
Russian Journal of Organic Chemistry (2022) Vol. 58, Iss. 12, pp. 1759-1768
Closed Access | Times Cited: 21
Phenylboronic acid-functionalized biomaterials for improved cancer immunotherapy via sialic acid targeting
Ashok Kumar Jangid, Kyobum Kim
Advances in Colloid and Interface Science (2024) Vol. 333, pp. 103301-103301
Closed Access | Times Cited: 3
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
lncHUB2: aggregated and inferred knowledge about human and mouse lncRNAs
Giacomo B. Marino, Megan L. Wojciechowicz, Daniel Clarke, et al.
Database (2023) Vol. 2023
Open Access | Times Cited: 10
Synthesis, anti-inflammatory activity, and acute toxicity of the substituted 2-[2-(4-nitrobenzoyl)hydrazono]-4-oxobutanoates
D. V. Lipin, S. K. Metlyakova, D. A. Shipilovskikh, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 8, pp. 1887-1893
Closed Access | Times Cited: 10
Protein-Based Virtual Screening Tools Applied for RNA–Ligand Docking Identify New Binders of the preQ1-Riboswitch
Elisabeth Kallert, Tim R. Fischer, Simon Schneider, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 17, pp. 4134-4148
Open Access | Times Cited: 15
Synthesis and antinociceptive activity of nitriles, esters, and amides of 2-amino-1-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-4-oxo-5-(2-oxo-2-arylethylidene)-4,5-dihydro-1H-pyrrole-3-carboxylic acids
D. V. Lipin, K. Yu. Parkhoma, V. M. Shadrin, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 8, pp. 1913-1920
Closed Access | Times Cited: 9
Ring Opening of Substituted 3-[2-(4-Nitrobenzoyl)­hydrazinylidene]furan-2(3H)-ones with Primary Alcohols. Analgesic Activity and Acute Toxicity of the Products
D. V. Lipin, E. I. Denisova, D. A. Shipilovskikh, et al.
Russian Journal of Organic Chemistry (2023) Vol. 59, Iss. 4, pp. 631-638
Closed Access | Times Cited: 8
Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
Anna Szymanowska, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 5, pp. 52-52
Open Access | Times Cited: 8
Synthesis and antinociceptive activity of N-substituted 4-aryl-2-[(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino]4-oxobut-2-enamides
I. A. Gorbunova, Elizaveta Okoneshnikova, Р. Р. Махмудов, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 8, pp. 1905-1912
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top